GCIA
MJN

Gabelli & Co Investment Advisers’s Mead Johnson Nutrition Company MJN Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-185,606
Closed -$16.5M – 186
2017
Q1 		$16.5M Buy
+185,606
New +$15.3M 1.85% 18
2016
Q4 		– Sell
-10,000
Closed -$790K – 173
2016
Q3 		$790K Hold
10,000
– – 0.09% 93
2016
Q2 		$908K Hold
10,000
– – 0.12% 88
2016
Q1 		$850K Hold
10,000
– – 0.11% 82
2015
Q4 		$790K Buy
10,000
+2,500
+33% +$197K 0.09% 96
2015
Q3 		$528K Sell
7,500
-7,500
-50% -$617K 0.07% 110
2015
Q2 		$1.35M Hold
15,000
– – 0.19% 65
2015
Q1 		$1.51M Hold
15,000
– – 0.25% 57
2014
Q4 		$1.51M Hold
15,000
– – 0.22% 62
2014
Q3 		$1.44M Buy
+15,000
New +$1.42M 0.23% 77

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Gabelli & Co Investment Advisers's MJN Position: Q2 2017 in Review

Gabelli & Co Investment Advisers sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 185,606 shares — an estimated $16.5M sold.

Gabelli & Co Investment Advisers first reported a position in MJN in Q3 2014 and held it in 10 quarters. The position peaked at $16.5M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Gabelli & Co Investment Advisers reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 185,606 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $16.5M.
  • Gabelli & Co Investment Advisers first reported a position in Mead Johnson Nutrition Company in Q3 2014 and held it in 10 quarters.
  • Gabelli & Co Investment Advisers's Mead Johnson Nutrition Company position peaked at $16.5M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2017, filed 3 Aug 2017.